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p97 is an ATP-dependent chaperone that plays an
important role in endoplasmic reticulum-associated
degradation but whose connections to turnover of
soluble proteins remain sparse. Binding of p97 to
substrates is mediated by cofactors that contain
ubiquitin-binding domains. We employed ‘‘network
proteomics’’ to show that p97 assembles with all of
the 13 mammalian UBX-domain proteins. The UBX
proteins that bind ubiquitin conjugates also interact
with dozens of E3 ubiquitin ligases, only one of which
had been previously linked to p97. In particular,
UBXD7 links p97 to the ubiquitin ligase CUL2/VHL
and its substrate hypoxia-inducible factor 1a
(HIF1a). Depletion of p97 leads to accumulation of
endogenous HIF1a and increased expression of
a HIF1a target gene. The large number of ubiquitin
ligases found associated with UBX proteins sug-
gests that p97 plays a far broader role than previ-
ously anticipated in the global regulation of protein
turnover.
INTRODUCTION
p97, also known as Cdc48 in yeast, is a homohexameric AAA
(ATPase associated with a variety of activities) ATPase, highly
conserved from archaebacteria to mammals. As one of the
most abundant proteins in the cell (Peters et al., 1990), p97/
Cdc48 performs a variety of functions ranging from cell-cycle
regulation to membrane fusion and protein degradation (Ye,
2006). The role of p97/Cdc48 in the ubiquitin-proteasome sys-
tem (UPS) was first revealed in a genetic screen for mutants
defective in the turnover of ubiquitin fusion proteins (the UFD
pathway) (Ghislain et al., 1996). However, the bulk of subsequent
p97 studies have focused on its role in endoplasmic reticulum-
associated protein degradation (ERAD). Typically, ERAD sub-
strates aremisfolded ormisassembled proteins, but ER-resident
enzymes like HMGR can also be regulated by this system (Dool-804 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.man et al., 2004; Hampton et al., 1996). Dislocation from the ER
back into the cytosol is a hallmark of ERAD, and p97 provides the
driving force for this process (Rouiller et al., 2002; Ye et al., 2001).
Also at the ER, yeast Cdc48 participates in the activation of the
transcription factors Spt23 and Mga2 by dissociating the active
subunits from their membrane-bound partners (Rape et al.,
2001; Shcherbik and Haines, 2007).
The most extensively studied p97 binding partners are p47
and the NPL4/UFD1 heterodimer, which form alternative com-
plexes with p97 and direct its activity to different cellular
processes. The NPL4/UFD1 adaptor is needed for the function
of p97 in UPS-dependent protein degradation, including the
ERAD pathway, while p47 enables p97 to participate in homo-
typic membrane fusion. The yeast p47 ortholog, Shp1, is also
involved in proteolytic events (Ye, 2006).
Many p97 functions, regardless of whether or not they are
associated with proteolysis, involve recognition of ubiquitinated
protein substrates. The p97/p47 complex can bind ubiquitinated
proteins via the UBA domain in p47, whereas the NPL4/UFD1
heterodimer performs the same function through the NPL4 zinc
finger (NZF) domain in NPL4 and the UT3 region in UFD1 (Meyer
et al., 2002; Park et al., 2005; Ye et al., 2003).
While p47 and NPL4/UFD1 are substrate-recruiting cofactors,
p97 also interacts with a variety of substrate-processing cofac-
tors like the E4 enzyme Ufd2 (Richly et al., 2005) or the deubiqui-
tinating enzymes VCIP135 (Uchiyama et al., 2002; Wang et al.,
2004) and Otu1 (Rumpf and Jentsch, 2006). With the exception
of Ufd2, all p97 cofactors enumerated above interact with the
N-terminal domain of p97. Ufd2 and another yeast Cdc48 cofac-
tor, Ufd3/Doa1, dock onto p97’s C terminus (Yeung et al., 2008).
Irrespective of its bound cofactors, the underlying function of
p97 is believed to be the conversion of the energy derived
from ATP hydrolysis into mechanical force used to disassemble
protein complexes or segregate polypeptides from intracellular
structures such as the ER membrane. p97 comprises three do-
mains: the N-terminal domain and two ATPase domains (D1,
D2). Structural studies revealed that the ATPase domains form
two hexameric rings stacked on top of each other with a pore
in the center. Multiple conformational changes have been ob-
served in the p97 hexamer during its ATPase cycle, and several
models have been proposed to explain how p97 ATPase activity
can be translated via the adaptors into tension applied on protein
substrates (Pye et al., 2006).
We describe a comparative proteomic study of mammalian
UBX domain-containing p97 cofactors. Our experiments unex-
pectedly revealed a large number of E3 ligases that interact
with a subset of UBX-domain proteins. Among these interac-
tions, we found that the UBX-domain protein UBXD7 bound
subunits of the CUL2/VHL ubiquitin ligase complex and its
substrate, HIF1a. We further show that HIF1a is a novel endog-
enous substrate of p97 and that UBXD7 mediates its interaction
with p97. Our results suggest that the role of p97 in ubiquitin-me-
diated proteolysis is far more pervasive than previously
envisioned.
RESULTS
Mammalian p97 Interacts with Multiple UBX
Domain-Containing Cofactors
To further understand themolecular basis for p97’s diverse func-
tions, we analyzed p97-Myc immunoprecipitates from human
293 cells by multidimensional protein identification technology
(MudPIT) (Link et al., 1999), searching for new p97 cofactors.
This analysis revealed eight p97 binding partners (Table 1), all
containing a UBX (structurally similar to ubiquitin) domain in their
C-terminal regions (Figure 1A). At the time of our analysis, p47
was the only human UBX-domain protein known to interact
with p97 (Kondo et al., 1997;Meyer et al., 2000), and the UBXdo-
main of p47 was known to be required for binding the N-terminal
domain of p97 (Uchiyama et al., 2002; Yuan et al., 2001).
The human proteome includes at least 13 different UBX pro-
teins (Figure 1A), some of which were not identified in our initial
analysis. At least three of those, UBXD1 (Carim-Todd et al.,
2001), Socius/UBXD5 (Katoh et al., 2002), and Rep-8/UBXD6
(Yamabe et al., 1997), are mainly expressed in the reproductive
organs and might be expressed poorly in the 293 kidney cell
line used for immunoprecipitation. Upon expressing their Flag-
tagged versions in 293 cells, we confirmed that 11 mammalian
UBX domain-containing proteins (five of which were absent in
the original p97 immunoprecipitates) coimmunoprecipitated en-
dogenous p97 (Figure 1B). Taken together, our mass spectrom-
etry and immunoprecipitation/western analyses confirmed that
all 13 mammalian UBX proteins bound p97. This is consistent
with the observation that all seven budding yeast UBX proteins
bind Cdc48 (Schuberth et al., 2004). Given that UBX proteins in-
variably bind p97/Cdc48, UBX emerges as a signature domain
for p97-binding partners across species.
There Are Two Classes of UBX Domain-Containing
Proteins Based on Their Ability to Bind Ubiquitinated
Substrates
Based on their domain composition, the human UBX proteins
can be divided into two main groups (Figure 1A). The first group
includes the UBA-UBX proteins (UBXD7, UBXD8, FAF1, SAKS1,
and p47), characterized by the presence of an ubiquitin-associ-
ated (UBA) domain at their N termini. The UBA domain binds
ubiquitin (Hurley et al., 2006) and, consistent with that, we found
that Flag-tagged UBA-UBX proteins coimmunoprecipitated en-
dogenous ubiquitin conjugates (Figure 1C). The amount of ubiq-uitinated proteins present in UBA-UBX protein immunoprecipi-
tates was amplified by proteasome inhibition with MG132
(Figure 2A), suggesting that at least some of them are UPS sub-
strates. The second group includes the UBX-only proteins,
which lack the UBA domain (Figure 1A) and the ability to bind
ubiquitinated substrates (Figure 1C).
To establish what type of ubiquitin chains are recognized by
mammalian UBA-UBX proteins, we searched our mass spec-
trometry data for ubiquitin tryptic peptides bearing GG signa-
tures (Parker et al., 2005). Multiple spectra corresponding to
ubiquitin peptides carrying a GG signature at K48 were identi-
fied, as expected for proteins targeted for proteasomal degrada-
tion (Pickart, 1997). However, it came as a surprise that a higher
number of peptides carried GG signatures attached to K11. The
detection of GG signature peptides by mass spectrometry is
most efficient for K48 and less effective for K11 (Kirkpatrick
et al., 2006), suggesting that the actual ratio of K11- to K48-
linked chains could be even higher than indicated by the spec-
trum counts shown in Figure 3A. While a more detailed analysis
will be required to unambiguously establish ubiquitin chain spec-
ificity, it is interesting to note that K11-linked chains were
detected in immunoprecipitates of all UBA-UBX proteins.
General Features of the UBX Protein
Interaction Networks
Because the biological functions for most UBX proteins are
largely unknown (Schuberth and Buchberger, 2008), we per-
formed a comparative MudPIT analysis of Flag-UBX protein
immunoprecipitates from transiently transfected 293 cells. The
resulting data sets were mined to identify interacting partners
that are shared among multiple UBX protein complexes, as
well as partners that are specific to a certain UBX protein.
We first focused our attention on known components of the
p97 network. NPL4/UFD1 and p47 use a similar bipartite mech-
anism for binding the N-terminal domain of p97 and compete for
p97 binding in vitro (Bruderer et al., 2004; Meyer et al., 2000).
This led to the hypothesis that the interaction of NPL4/UFD1
and UBX proteins with p97 might be mutually exclusive. How-
ever, the bipartite p97-binding motif seems to be conserved
only in SEP-UBX proteins like p47 (Bruderer et al., 2004) and
Table 1. UBX-Domain Proteins Identified by Mass Spectrometry









p47 40573 19 153 52.2%
UBXD8 52624 11 12 33.7%
p37 37077 6 7 32.3%
UBXD7 54862 8 12 29.0%
SAKS1 33325 2 2 19.5%
UBXD4 29278 4 5 19.3%
ASPL 60183 7 13 17.2%
FAF1 73954 7 11 8.2%
The number of unique peptides identified (sequence count) is indicated,
as is the total number of peptides (spectrum count), which takes into ac-
count that some peptides were identified multiple times.Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc. 805
Figure 1. Mammalian UBX-Domain Proteins Interact with p97 and Some Serve as Ubiquitin Receptors
(A) The domain composition of human UBX proteins. Those identified in p97-Myc immunoprecipitates are indicated in red. UBA, ubiquitin-associated; UIM, ubiq-
uitin-interacting motif; UBL, ubiquitin-like; ThF, Thioredoxin-like fold. Further information about the respective domains can be found at http://www.ebi.ac.uk/
interpro/.
(B–D) N-terminally Flag-tagged UBX proteins were expressed in 293 cells and immunoprecipitated using anti-Flag beads. Cells expressing Flag-NPL4 or no Flag-
tagged protein were used as positive and negative control, respectively. Some of the endogenous proteins that were coimmunoprecipitated are shown in western
blots using specific antibodies. ‘‘(Ubi)n’’ refers to ubiquitin chains of varying length.p37 (Uchiyama et al., 2006), leaving open the possibility that
other UBX-domain proteins use a different binding mode. We
confirmed, both by mass spectrometry (Table S1 available on-
line) and by immunoblotting of Flag-p47 immunoprecipitates
(Figures 1D and 2A), that, for the most part, p47 does not form
complexes with NPL4/UFD1. That seems to be an exception
rather than the rule, as the other UBA-UBX proteins coimmuno-
precipitated NPL4 and UFD1. Conversely, Flag-NPL4 coimmu-
noprecipitated UBA-UBX proteins, with most peptides identified
for the UBA-UAS-UBX proteins UBXD8, UBXD7, and FAF1 (data
not shown). Similarly, the yeast UBA-UBX protein Ubx2 assem-
bles into a Cdc48/Npl4/Ufd1/Ubx2 complex (Schuberth and
Buchberger, 2005).
We also compared the ability of UBX proteins to interact with
substrate-processing cofactors of p97. VCIP135 seems to inter-
act preferentiallywithSEP-UBXproteins like p47andUBXD5 (Ta-
bleS1). Indeed, twoSEP-UBXproteins,p37andp47,both require
VCIP135 for their function (Uchiyama et al., 2006). PLAP, known
asUfd3/Doa1 in budding yeast, has a strongpreference for coas-806 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.sembling with SAKS1 (Figure 1D). Intriguingly, even though yeast
Npl4/Ufd1 andUfd3bind to distinct regions of Cdc48 (Rumpf and
Jentsch, 2006), in our analysis, the complexes that are richest in
NPL4/UFD1 are poorest in PLAP and vice versa (Figure 1D and
Table S1). With the exception of a few peptides identified in
SAKS1 and p47 immunoprecipitates, UBE4B, the human ortho-
log of yeast Ufd2, was largely absent from our UBA-UBX protein
and p97 immunoprecipitates (Table S2).
It has been proposed that yeast Cdc48 functions in series with
other targeting factors like Rad23 tomediate processing of ubiq-
uitin conjugates and their eventual presentation to the protea-
some (Medicherla et al., 2004; Richly et al., 2005). Although
this model contemplates the formation of ternary complexes,
we found that RAD23 and ubiquilins were largely absent from
our UBX protein and p97 immunoprecipitates. However, we
did identify multiple proteasome subunits, most frequently the
proteasome base subunits PSMC3, PSMC4, and PSMD1 (data
not shown), which made us speculate that, in human cells,
p97-substrate complexes might directly dock onto the
Figure 2. UBA-UBX Proteins Interact with Ubiquitinated Proteins Destined for Degradation and with Various E3 Ligases
(A and B) Flag-tagged UBA-UBX proteins were immunoprecipitated from 293 cells treated for 2 hr with DMSO orMG132. Cells expressing no Flag-tagged protein
were used as negative control. Some of the endogenous proteins that coimmunoprecipitated were detected by western blotting using specific antibodies. CUL2
input levels are shown at the bottom of (B).
(C) The indicated Flag-tagged proteins were immunoprecipitated from HeLa cells treated with MG132 as above. AMSH, a protein that is not part of the p97 net-
work, was used as negative control. UBXD7D and p47D are truncation mutants lacking the UBX domain. The UBA domain by itself was expressed at very low
levels. The indicated proteins were detected using specific antibodies in the immunoprecipitates (top) and the input cell extracts (bottom). Ubi, ubiquitin.proteasome base without another targeting factor acting as an
intermediary.
Notably, there was little crossinteraction between different
UBX proteins (data not shown), suggesting that they form homo-
meric complexes with p97.UBA-UBX Proteins Interact with a Large Variety
of E3 Ubiquitin Ligases
A striking observation from the comparative MudPIT analysis of
Flag-tagged UBA-UBX protein immunoprecipitates was their
ability to interact with numerous E3 ligases as indicatedCell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc. 807
Figure 3. The E3 Interaction Network for UBA-UBX Proteins
(A) The number and type of GG signature peptides identified bymass spectrometry in Flag-tagged UBA-UBX protein immunoprecipitates is indicated. D, DMSO;
M, MG132.
(B) Osprey diagram illustrating the set of E3 ligases interacting with each UBA-UBX protein.
(C) Quantitative representation of the interactions shown in B, obtained by calculating for each E3 ligase the abundance factor (AF) relative to p97. For details, see
Table S2 and its legend.qualitatively in Figure 3B. We identified multiple components of
cullin-RING E3 ligase (CRL) complexes but also single subunit
RING- and HECT-domain E3s. Of these 38 ubiquitin ligases,
more than a third were also identified in p97 immunoprecipitates
(marked by footnote ‘‘a’’ in Table S2), confirming that they belong
to the p97 network.
Individual UBA-UBX proteins did not exhibit strict specificity
for particular E3 ligases, but at least some E3s seemed to be
enriched in certain UBA-UBX protein immunoprecipitates
(Figure 3C). Most notably, UBXD7 showed a remarkable ability
to coimmunoprecipitate CUL2. Moreover, we also identified
RBX1, elongin B, elongin C, and VHL in UBXD7 immunoprecip-
itates. In general, UBXD7was the UBA-UBX protein that showed
the most extensive interaction with CRL subunits (Figures 2B
and 3C). An UBXD7mutant lacking the UBX domain lost the abil-
ity to interact not only with p97 but also with ubiquitinated808 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.substrates (Figure 2C). Despite that, truncated UBXD7 largely
retained its capacity to bind CUL1 and CUL2. In contrast,
a p47 mutant lacking the C-terminal region could still pull down
ubiquitinated proteins but did not exhibit significant binding of
cullins. This lack of correlation between ubiquitin and E3 binding,
together with semiquantitative analysis of the MudPIT data
(Figure 3C), suggests that the interaction between UBA-UBX
proteins and E3 ligases is specific and not simply mediated by
the ubiquitinated substrate binding to the UBA domain.
UBXD7 Interacts with HIF1a in a Manner that Is Largely
Independent of p97
p97 cofactors like p47 and NPL4/UFD1 mediate the interaction
between p97 and its ubiquitinated targets (Ye, 2006). ByMudPIT
analysis of individual UBX-protein immunoprecipitates, we
sought to identify p97 targets specific for these cofactors and
Figure 4. UBXD7 Interacts with Endogenous HIF1a Independently of p97
(A) HIF1a peptides identified by mass spectrometry in Flag-UBXD7 immunoprecipitates from cells treated with MG132 for 2 hr.
(B) The Flag-tagged UBA-UBX protein immunoprecipitates shown in Figure 2A were separated by PAGE and blotted using HIF1a-specific antibodies (top). The
bottom panel shows equivalent HIF1a levels in the input-cell extracts.
(C) The specificity of HIF1a antibodies was tested on total-cell extracts from HeLa cells treated with the indicated concentration of HIF1a siRNA in the presence
and absence of a 2 hr treatment with MG132. A crossreacting band partially overlapping with full-length HIF1a is indicated with an asterisk.
(D) Flag-UBXD7 was immunoprecipitated from HeLa cells treated with 5 nM of the indicated siRNAs for 48 hr. Where indicated, 20 mMMG132 was added for 2 hr
prior to harvesting the cells. The indicated proteins were detected using specific antibodies in the immunoprecipitates (left) and the input-cell extracts (right). Luc,
luciferase.thereby unravel which p97 functions they regulate. Therefore, we
were intrigued to identify eight distinct HIF1a peptides in Flag-
UBXD7 immunoprecipitates from cells in which the proteasome
activity was inhibited with MG132 (Figure 4A). HIF1, a heterodi-
meric transcription factor that consists of HIF1a and HIF1b sub-
units, regulates transcription in response to changes in O2
concentration. O2-dependent degradation of HIF1a is mediated
by prolyl-hydroxylase, the CUL2/VHL ubiquitin ligase, and theproteasome (Ivan and Kaelin, 2001). Thus, we decided to pursue
HIF1a as a potential p97/UBXD7 substrate.
Among the UBA-UBX proteins, UBXD7 was by far the most ef-
ficient in coimmunoprecipitating endogenous HIF1a, which was
detected as an ubiquitinated ladder using anti-HIF1a antibodies
(Figure 4B). HIF1a is scarce in normoxia (Huang et al., 1996);
hence, the interaction between UBXD7 and HIF1a was only de-
tectable after MG132 treatment, which causes accumulation ofCell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc. 809
Figure 5. UBXD7 Recruits p97 to HIF1a
(A) p97-Myc was immunoprecipitated from HeLa cells treated or not with 20 mM MG132 for 2 hr prior to harvesting the cells. Cells expressing no Myc-tagged
protein were used as negative control. The indicated proteins were detected in the immunoprecipitates (top) and the input-cell extracts (bottom) using specific
antibodies.
(B) p97-Myc was immunoprecipitated from HeLa cells treated for 48 hr with 5 nM of the indicated siRNAs and incubated with MG132 as above. The indicated
proteins were detected using specific antibodies in the immunoprecipitates (left) and the input-cell extracts (right). Luc, luciferase.
(C) HeLa-cell extracts were fractionated on a Superdex 200 gel filtration column. Individual fractions were concentrated by TCA precipitation and subjected to
western blotting using specific antibodies. All proteins were endogenously expressed.ubiquitinatedHIF1a.Weconfirmed the specificity of theHIF1a an-
tibodies by comparing the signal in total-cell extracts from cells
treatedornotwithHIF1asiRNA,both in thepresenceandabsence
ofMG132 (Figure4C). This indicated thepresenceofa crossreact-
ing band that partially overlapswith full-lengthHIF1a,markedwith
asterisks in all the panels showing HIF1a in total-cell extracts. The
crossreacting band was absent from immunoprecipitates
(Figure 4D). Proteasome inhibition also caused accumulation of
HIF1a partial degradation products (Figure 4C) that migrated
faster than expected for the full-length protein (92.7 kDa), some
of which also coimmunoprecipitated with UBXD7 (Figure 4B).810 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.We next tested whether the interaction between UBXD7 and
HIF1a depends on p97. Depletion of p97 by siRNA did not alter
significantly the interaction of UBXD7 with HIF1a or cullins, but it
drastically reduced the association of UBXD7 with NPL4 and
UFD1 (Figure 4D). Therefore,we conclude that UBXD7 interaction
with the substrate and E3s does not depend on p97/NPL4/UFD1.
UBXD7 Recruits p97 to HIF1a
To validate that the interaction of UBXD7 with HIF1a occurs
within the p97 network, we showed that p97 itself coimmunopre-
cipitated endogenous HIF1a (Figure 5A). Interestingly, the HIF1a
that immunoprecipitated with p97wasmore extensively polyubi-
quitinated than the pool bound to UBXD7 (compare Figures 5A
and 5B with Figures 4B and 4D). The accumulation of ubiquiti-
nated HIF1a in p97 immunoprecipitates after proteasome inhibi-
tion correlated with increased amounts of endogenous UBXD7
bound to p97 (Figure 5A), suggesting that UBXD7 binding to
p97 might depend on the availability of substrate. Further sup-
port for this idea came from gel filtration experiments of HeLa
cell extracts in which all proteins were expressed endogenously
(Figure 5C). We observed two fractionation peaks for endoge-
nous UBXD7, only one of which overlappedwith p97. In contrast,
NPL4 and UFD1 fractionation closely resembled p97. This frac-
tionation pattern indicated that the default state for NPL4/UFD1
was p97 bound, whereas only a fraction of UBXD7 was p97
bound, possibly in response to a stimulus such as interaction
with a substrate. Indeed, the accumulation of ubiquitinated sub-
strates upon proteasome inhibition by MG132 resulted in a shift
of UBXD7 toward p97-positive fractions (Figure S1A), a phenom-
enon that was reverted upon p97 depletion (Figure S1B).
If the substrate-ligase complex binds UBXD7, which in turn
binds p97, HIF1a association with p97 should depend on
UBXD7. Indeed, the ability of p97 to coimmunoprecipitate en-
dogenous HIF1a-ubiquitin conjugates was lost in cells treated
with UBXD7 siRNA (Figure 5B). In contrast, UBXD7 depletion
had no significant effect on NPL4, UFD1, or polyubiquitin binding
to p97. While CUL1 binding to p97 was also unaffected by
UBXD7 depletion, we observed a significant reduction of CUL2
binding (Figure 5B), consistent with UBXD7 being the best
CUL2 binder among UBA-UBX proteins (Figure 2B). This sug-
gests that the UBA-UBX adaptor mediates p97 interaction with
the substrate and the corresponding E3 ligase.
HIF1a Is a Novel p97 Substrate
The endogenous HIF1a that interacted with both UBXD7 and
p97 was mainly ubiquitinated and accumulated upon protea-
some inhibition (Figures 4B, 4D, and 5A), supporting the idea
that it was destined for UPS-dependent degradation.
To test whether p97 regulates HIF1a degradation, we per-
formed siRNA-mediated depletion experiments. Figure 6A
shows the effect of various siRNA pools on HIF1a levels in to-
tal-cell extracts. p97 depletion caused accumulation of endoge-
nous HIF1a as species > 100 kDa and >> 250 kDa, and this effect
was amplified by brief exposure to MG132 (Figure 6A, compare
lane 1 with 2 and lane 8 with 9). However, p97 depletion did not
promote HIF1a accumulation as effectively as proteasome inac-
tivation. This could be due to various reasons: (1) the low
amounts of p97 that remain in the cell after siRNA treatment
may be sufficient to promote HIF1a degradation, (2) other target-
ing factors, like Rpn10/PSMD4, RAD23, or ubiquilins, may be
able to partially compensate for the lack of p97, or (3) only a sub-
set of ubiquitinated HIF1a molecules depend on p97 for degra-
dation. p97 depletion also caused a mild increase in the total
pool of ubiquitinated proteins (Figure 6A, compare lane 1 with
2). The p97 siRNA pool did not alter HIF1a mRNA levels
(Figure 6B), indicating that the observed effects at the protein
level were most likely due to perturbations in HIF1a degradation.
As a measure of HIF1a activity, we analyzed the levels of
carbonic anhydrase IX (CA IX), an established target of HIF1atranscriptional activity (Wykoff et al., 2000). CA IX protein levels
were very low in normoxia (Figure 6A, lane 1) but accumulated
in cells depleted of p97 (Figure 6A, lanes 2 and 9). It has been re-
ported by several groups that HIF1a that accumulates in the
presence of MG132 is transcriptionally inactive (Kaluz et al.,
2008), and this explains why MG132 had a major effect on
HIF1a levels but little effect on CA IX levels.
We next confirmed that individual p97 siRNA oligonucleotides
behaved similarly to the p97 siRNA pool (Figure 6C, lanes 8–12).
Even if the amplitude of the effect varied among siRNAs, the gen-
eral trendwas thesame:p97depletion led toHIF1aaccumulation.
Taken together, our results suggest that efficient HIF1a degra-
dation depends on p97, thereby establishing HIF1a as the first
endogenous substrate of mammalian p97 that is not associated
with the ER.
Given that UBXD7 recruits HIF1a to p97 (Figure 5B), we
thought that UBXD7 depletion would phenocopy p97 depletion.
Thus, it was unexpected to see that UBXD7 depletion caused
a reduction in both full-length and ubiquitinated HIF1a
(Figure 6A). The contrast between p97 and UBXD7 depletion
was most obvious upon brief treatment with MG132
(Figure 6A, lanes 9–11). This result was confirmed by three of
the four siRNA oligonucleotides in the UBXD7 siRNA pool
(Figure 6C, compare lane 2 with lanes 3, 4, 6, and 7). Moreover,
when the cells were treated with a combination of UBXD7 and
p97 siRNAs, UBXD7 depletion seemed to partially offset the
lack of p97 (Figures 6A and S2). As elaborated in the discussion
section, we speculate that, in the absence of UBXD7, HIF1a
does not engage the p97 network and is more readily available
to alternative proteasome receptors.
The protein levels of CA IX perfectly mimicked those of HIF1a
(Figure 6A); they were highest in cells depleted of p97 (lanes 2
and 9), lowest in cells depleted of UBXD7 (lanes 3–5 and 10,
11), and intermediate in cells depleted of both UBXD7 and p97
(lanes 6 and 12). As for p97, the UBXD7 siRNA pool did not
have a significant effect on HIF1a mRNA levels (Figure 6B).
DISCUSSION
The role of the p97/Cdc48 ATPase in ubiquitin-dependent prote-
olysis has been studied intensively over the past several years,
mainly from the perspective of the important contribution that it
makes to ERAD. Despite the prevalent ER-centric view of p97
function, hints have emerged that p97 plays a broader role in reg-
ulating the turnover of UPS substrates. For example, p97/Cdc48
has been implicated in the turnover of the protein kinase Cdc5
(Cao et al., 2003), the Cdk inhibitor Far1 (Fu et al., 2003), and
the myosin chaperone UNC45 (Janiesch et al., 2007). However,
it remains unknown how pervasive p97’s non-ER functions are.
In the work reported here, we sought to gain greater insight
into p97 biology by performing a focused ‘‘network proteomics’’
analysis (Graumann et al., 2004) of p97 and its UBX-domain co-
factors. Two major insights have emerged from this effort. First,
we found that UBA-UBX proteins associate with an unexpect-
edly broad range of ubiquitin ligases, including cullins 1 through
4, nine RING ligases, and three HECT domain enzymes. Among
these, p97 has been linked previously only to the ERAD-related
ubiquitin ligase gp78 (Zhong et al., 2004). Given the greatCell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc. 811
Figure 6. p97 Promotes HIF1a Degradation
(A) Total-cell extracts were prepared from cells treated with 5 nM of the indicated siRNA pools unless another siRNA concentration is specified. The siRNA treat-
ment was 48 hr, and it was combined or not with 2 hr of MG132 treatment. The indicated proteins were detected using specific antibodies. U7, UBXD7. A non-
specific band crossreacting with the HIF1a antibodies is indicated with an asterisk.
(B) HIF1a mRNA was amplified by RT-PCR using specific primers. 18S rRNA was amplified as control.
(C) Total-cell extracts were prepared from cells treated with 5 nM of the indicated siRNA oligonucleotides or pools (p) for 48 hr and incubated with 20 mMMG132
for 2 hr. The indicated proteins were detected using specific antibodies. A nonspecific band crossreacting with the HIF1a antibodies is indicated with an asterisk.
(D) UBXD7 recruits p97/NPL4/UFD1 to the ubiquitinated substrate and prevents its interaction with other proteasome-targeting factors. (Top) (1) UBA and UBX
domains inactivate each other when the protein is not bound to the substrate. (2) Substrate oligo-ubiquitination or attachment of multiple monoubiquitin allows
recruitment of several UBA-UBX molecules per substrate. UBA domains mask the emerging ubiquitin chain and prevent substrate degradation. (3) Substrate
binding frees the UBX domains that become available to recruit p97/NPL4/UFD1. The ubiquitin chain is elongated, and the substrate is delivered to the protea-
some for degradation. (Bottom) In the absence of UBXD7, other proteasome-targeting factors mediate accelerated substrate degradation. The Rpn10/PSMD4
subunit of the proteasome is depicted as an alternative ubiquitin receptor. S, substrate; E3, ubiquitin ligase.number of CRLs expressed in human cells and their intimate
connection to a broad range of regulatory processes, our find-
ings suggest that the substrate repertoire of p97 is far more
diverse than previously appreciated and nominate p97 as a can-812 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.didate regulator of numerous processes in which it has not pre-
viously been implicated. The second major finding, which flows
directly from the first, is that we have forged a direct and unex-
pected functional connection between p97 and HIF1a, which is
the key governor of cellular and organismal responses to oxygen
tension.
Network Proteomics Provides Novel Insights into p97
Biology
Our analysis of the p97 proteome has unearthed a trove of obser-
vations that challenge some current assumptions about p97/
Cdc48. First, our findings imply that ERAD may comprise but
a small fraction of p97’s role in the UPS. This is consistent with
CDC48 being an essential gene in yeast, whereas ERAD is
dispensable (Swanson et al., 2001). Second, we challenged the
notion that UBX proteins and NPL4/UFD1 form mutually exclu-
sive complexes with p97. This view is based on molecular analy-
sis of p47, which our results reveal may be the exception, rather
than the rule. Other UBX-domain proteins, including UBXD7,
UBXD8, andFAF1, clearly formhigher-order complexes that con-
tain p97 and NPL4/UFD1. Third, our proteomic findings suggest
that substrate-processing cofactors such as VCIP135, PLAP,
and UFD2 may be restricted to specific UBX-protein/p97 com-
plexes. Fourth, we noted an unexpected prevalence of K11-
linked ubiquitin chains in pull-downs of UBA-UBX proteins.
Taken together, our findings demonstrate how network pro-
teomics can provide a broad view that is not accessible from
the analysis of a single component.
The Role of p97 and UBXD7 in HIF1a Turnover
In the second half of the work described here, we took one ob-
servation from the proteomic analysis and investigated it in
depth. Specifically, we delved into the finding that, in cells
treated with MG132, UBXD7 coimmunoprecipitated all compo-
nents of the CUL2/VHL ubiquitin ligase, as well as its most prom-
inent substrate, HIF1a. Although HIF1ametabolism has been the
focus of intensive investigation, it has not been previously linked
to p97 in any way.
Using UBXD7 as a prototype UBA-UBX protein and HIF1a as
a model substrate, we gained new insights into the role of UBA-
UBX adaptors within the p97 network. Three observations led us
to suggest that substrate binding to UBXD7 precedes the forma-
tion of UBXD7 complexes with p97/NPL4/UFD1 and may be
a prerequisite for it: (1) the interaction of UBXD7 with the
substrate and E3 does not depend on p97/NPL4/UFD1, whereas
the interaction of p97/NPL4/UFD1 with substrate and E3 re-
quires UBXD7, (2) UBXD7 binding to p97 increases upon protea-
some inhibition and accumulation of substrate, as shown by
immunoprecipitation and gel filtration experiments, and (3) in
contrast to NPL4/UFD1, a considerable pool of endogenous
UBXD7 is not bound to p97. By analogy to the idea that UBL
and UBA domains can undergo intramolecular association
(Lowe et al., 2006; Ryu et al., 2003), it is conceivable that UBX
and UBA domains interact with each other, intra- or intermolec-
ularly, therebymaintaining UBXD7 in an inactive state (Figure 6D,
section 1). Only after the UBA domain engages an ubiquitinated
substrate would the UBX domain become available to recruit the
p97/NPL4/UFD1 complex through interaction with the N-termi-
nal domain of p97 (Figure 6D, sections 2 and 3).
An important complement to the binding studies that linked
HIF1a to UBXD7 and p97 was a series of siRNA knockdown ex-
periments. We found that endogenous HIF1a accumulates incells depleted of p97, while the opposite is seen when cells are
depleted of UBXD7. To explain this apparent paradox, we
propose a two-step function for UBXD7 in mediating HIF1a deg-
radation via the p97 pathway. Binding of UBXD7 to ubiquitinated
HIF1a commits it to the p97 pathway and shields it from other
proteasome-targeting factors. A protective role of UBXD7 that
precedes its role in recruiting p97/NPL4/UFD1 would explain
the observed discrepancy between the UBXD7 and p97 siRNA
results. In cells depleted of p97, ubiquitinated HIF1a becomes
trapped in nonproductive complexes with UBXD7. However, in
cells depleted of UBXD7, ubiquitinated HIF1a cannot be guided
into the p97 pathway and is free to engage other targeting factors
or the proteasome itself through its Rpn10/PSMD4 or Rpn13
subunits (Figure 6D, bottom). This would provide a more expedi-
tious route for degradation than the pathway gated by UBXD7,
hence, the observed reduction in HIF1a levels.
In contrast to the results we obtained for UBXD7 and HIF1a,
deletion of yeast UBX2 causes stabilization of ERAD substrates
(Neuber et al., 2005; Schuberth and Buchberger, 2005). The dif-
ference between the behavior of HIF1a and that of ERAD
substrates upon depletion of the respective UBA-UBX adaptor
protein might be due to the fact that ERAD includes an ER retro-
translocation step. In the case of ER-associated substrates, p97
provides the driving force for their retrotranslocation through the
ER membrane (Ye, 2006), which makes it irreplaceable by other
targeting factors lacking the ATPase activity. As a soluble sub-
strate, HIF1a relinquishes such a requirement.
HIF1a is the first known UBA-UBX protein ligand that is not as-
sociated with the ER; hence, the generality of its behavior in the
absence of UBXD7 must await the identification of other recep-
tor-ligand pairs. While elucidating the exact role played by
UBXD7 in HIF1a degradation will require further studies, the
p97 siRNA results clearly indicate a role for p97 in HIF1a degra-
dation. Taken together, our results highlight the complexity of the
substrate targeting and processing pathways that operate
downstream of ubiquitin ligases and upstream of the protea-
some and call attention to the need for further studies to eluci-
date these pathways in greater detail.
Why Choose p97 as a Proteasome-Targeting Factor?
Depletion of p97 causes less accumulation of HIF1a than does
inhibition of the proteasome, suggesting the possibility that
p97 is involved in the degradation of only a subset of HIF1amol-
ecules. Perhaps p97 is required to degrade only thosemolecules
that exist in a particular assembly state, i.e., bound to HIF1b, pro-
moter DNA, and/or general transcription machinery. Indeed, p97
is known to function as an ‘‘unfoldase’’ of protein aggregates
(Kobayashi et al., 2007), as a ‘‘dislocase’’ of ERAD substrates
(Bar-Nun, 2005), or as a ‘‘separase’’ in Spt23/Mga2 activation
(Rape et al., 2001; Shcherbik and Haines, 2007). In the absence
of UBXD7, HIF1a degradation would occur without benefit of the
functions provided by p97. We suggest that p97-independent
degradation may be less processive or, possibly, less selective
for the ubiquitin-conjugated subunit of a protein complex.
K11 versus K48
As indicated above, K11 linkages of ubiquitin were unexpectedly
prominent in UBA-UBX immunoprecipitates. The UBA domainsCell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc. 813
of RAD23 interact with a surface of ubiquitin that includes K48
(Ryu et al., 2003), and they inhibit assembly of K48-linked chains
in vitro (Ortolan et al., 2000; Raasi and Pickart, 2003). If UBA-
UBX proteins employed a similar binding mode, their UBA
domains would be masking K48 of ubiquitin, thereby favoring
modification of alternative lysine residues such as K11. The un-
expected prominence of K11-linked chains reported here could
explain why these linkages were estimated to be equiabundant
with K63-linked chains in budding yeast cells (Peng et al., 2003).
Moreover, K11-linked ubiquitin chains accumulate in neurode-
generative disorders associated with protein aggregation, like
Alzheimer’s (Cripps et al., 2006) or Huntington’s disease (Ben-
nett et al., 2007). Mutations in p97 are the underlying cause for
the syndrome of inclusion body myopathy with Paget’s disease
of the bone and frontotemporal dementia (IBMPFD; Watts et al.,
2004), and p97 colocalizes with protein aggregates in Hunting-
ton’s, Machado-Joseph, and Parkinson’s disease (Hirabayashi
et al., 2001; Mizuno et al., 2003). K11 linkages can be generated
by the ubiquitin ligase APC/C working in concert with the E2 en-
zymes Ubc4 and UbcH10 (Kirkpatrick et al., 2006). Very recently,
Rape and colleagues reported that K11 linkages are required for
the turnover of APC/C substrates (Jin et al., 2008). Taken to-
gether, these observations suggest an unexpected connection
between APC/C, p97, and human disorders rooted in defective
protein homeostasis.
EXPERIMENTAL PROCEDURES
Antibodies, Reagents, and Plasmids
The following antibodies have been used: anti-Flag, anti-ubiquitin (Sigma),
anti-p97 (Research Diagnostics), anti-NPL4 (Abnova), anti-UFD1, anti-CUL3
(BD Transduction Laboratories), anti-PLAP (Epitomics), anti-CUL1, anti-
CUL2 (Zymed), anti-VHL (Santa Cruz Biotechnology), anti-UBR1 (courtesy of
A. Varshavsky lab), anti-HIF1a (Novus), anti-UBXD7 (courtesy of Millipore),
anti-UBXD8 (Imgenex), and anti-CA IX (courtesy of J. Pastorek and S. Pastor-
ekova). MG132 was purchased from Biomol. The truncation mutants were
obtained by site-directed mutagenesis. STOP codons were placed at the cor-
responding position in the wild-type plasmid such that the Flag-UBXD7DUBX
construct expresses UBXD7(1–400), Flag-UBA expresses UBXD7(1–62), and
Flag-p47DUBX expresses p47(1–232). See Table S3 for the list of wild-type
plasmids used in this study.
Cell Extracts and Immunoprecipitation
For immunoprecipitation experiments, the cells were lysed in buffer A (50 mM
HEPES/KOH (pH 7.5); 5 mMMg(OAc)2; 70 mMKOAc; 0.2% Triton X-100; 10%
glycerol; 0.2 mM EDTA; protease inhibitors) and incubated with anti-Flag aga-
rose beads (Sigma) or anti-Myc sepharose beads (Covance).
Total extracts of cells treated with siRNA were prepared using buffer B
(50 mM HEPES/KOH (pH 7.2); 400 mM NaCl; 1% NP-40; 0.2 mM EDTA;
10% glycerol; protease inhibitors) to enable extraction of nuclear HIF1a.
Mass Spectrometry Analysis
Mass spectrometrical sample analysis was performed as described previously
(Graumann et al., 2004) using a high-pressure liquid chromatography pump
(Agilent) in line to a LCQ DecaXP electrospray ion trap mass spectrometer
(ThermoFinnigan). In brief, 2–4 mg of protein extract was incubated with
anti-Flag beads, and the immunoprecipitated proteins were eluted with satu-
rated urea. The eluates were then proteolitically digested using sequentially
endoproteinase Lys-C and trypsin. The resulting peptide mixtures were pres-
sure loaded onto triphasicmicrocapillary columns, and sample separation was
achieved using a chromatography program consisting of six salt steps, each
followed by an organic gradient. The eluting peptides were electrosprayed
into the mass spectrometer, and the column eluate was continuously ana-814 Cell 134, 804–816, September 5, 2008 ª2008 Elsevier Inc.lyzed. One full-range mass scan (400–1400 m/z) was followed by three data-
dependent tandemmass spectrometry (MS/MS) spectra. Sequence database
matching was performed against the IPI human database (Kersey et al., 2004)
version 3.15.1 using Sequest (Eng et al., 1994), and the results were filtered
with DTASelect (Tabb et al., 2002), using the parameters indicated in Grau-
mann et al. (2004).
siRNA-Mediated Protein Depletion
siRNA oligonucleotides purchased from Dharmacon were transfected into
HeLa cells using Oligofectamine (Invitrogen) and the protocol suggested by
the manufacturer. See Table S4 for a list of the siRNAs used. The cells were
lysed 48 hr after siRNA transfection.
RT-PCR
RNA was isolated with the RNeasy Mini kit (QIAGEN). cDNA was synthesized
using Omniscript reverse transcriptase (QIAGEN) and specific primers. PCR
amplification was performed using the HotStarTaq DNA polymerase (QIAGEN)
and specific primers chosen to yield short DNA fragments of 200–300 base
pairs. Primer sequence is indicated in Table S5. The protocols were those sug-
gested by QIAGEN.
Gel Filtration
HeLa cell lysates in buffer C (50 mM HEPES/KOH [pH 7.2]; 5 mM Mg(OAc)2;
70 mM KOAc; 0.2% Triton X-10; 5% glycerol; 0.2 mM EDTA; protease inhibi-
tors) were fractionated on a Superdex 200 column (GE Healthcare). The
collected fractions were concentrated by TCA precipitation prior to western
blot analysis.
The molecular weight standards were Thyroglobulin (670 kDa; Bio-Rad),
Apoferritin (443 kDa; Sigma), and g-globulin (158 kDa; Bio-Rad).
SUPPLEMENTAL DATA
Supplemental Data include two figures and five tables and can be found with
this article online at http://www.cell.com/cgi/content/full/134/5/804/DC1/.
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